
PURR Stock Forecast & Price Target
PURR Analyst Ratings
Bulls say
Hyperliquid Strategies is attractive because its core value driver is the accumulation of HYPE, with holdings rising from 12.9 million at the end of December 2025 to 29.4 million, and projected to reach 33.9 million by calendar 2027, while cash of $149.9 million at quarter end and $132.6 million currently supports continued purchases. Its operating leverage is improving as fiscal Q4 revenue of $6.4 million beat estimates, opex fell to $4.2 million from $7.2 million after the legacy healthcare exit, and staking income is expected to cover operating costs in the second half of this calendar year. Additional upside comes from the May validator with Unit, which lifted delegated HYPE from 12.8 million in mid-May to 20.9 million currently, adding yield and commissions while NAV sensitivity remains tied to a larger HYPE base and higher token prices.
Bears say
Hyperliquid Strategies is exposed to a highly fragile valuation framework because its perceived upside depends almost entirely on the market price of HYPE, a volatile asset that is expected to remain volatile over the forecast horizon. Even using a calendar year-end 2027 forecast of 33.9 million HYPE and a $60 HYPE price, the implied $2.0 billion NAV is only modestly supported by an mNAV multiple of 1.05x, suggesting limited margin for error. The stock also faces meaningful execution and policy risks, including regulatory and legislative changes, competition from other digital asset treasury companies, constrained access to capital markets, and dependence on the continued health and growth of the Hyperliquid DEX.
This aggregate rating is based on analysts' research of Hyperliquid Strategies Inc and is not a guaranteed prediction by Public.com or investment advice.
PURR Analyst Forecast & Price Prediction
Start investing in PURR
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Hyperliquid Strategies Inc (PURR) Forecast
PURR Analyst Forecast & Price Prediction
Start investing in PURR
Order type
Buy in
Order amount
Est. shares
0 shares